Skip to main content
Premium Trial:

Request an Annual Quote

Specialty Laboratories Joins Siemens and Sequenom to Evaluate MassArray for Clinical Dx

NEW YORK, April 5 (GenomeWeb News) - Speciality Laboratories will help Sequenom and Siemens to validate Sequenom's MassArray genotyping platform for clinical diagnostics, the San Diego-based company said today.

 

Under the collaboration, Sequenom will install its MassArray Compact system at Specialty's clinical laboratory facility, where the platform's analytical data quality and current workflow will be evaluated in a benchmarking study expected to be completed by the fourth quarter of 2005.

 

The deal is part of an agreement between Siemens and Sequenom from late 2004, under which Siemens has bought and plans to install four MassArray systems in certain diagnostics and clinical labs in Europe and North America.

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.